APO Research
Talk to an analyst

APO RESEARCH · REPORT

Obstetric Risk Assessment Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Obstetric Risk Assessment Solutions Market Outlook and Growth Opportunities 2026

12 August 2026190 pages

Choose your research edition.

Industry ResearchObstetric Risk Assessment Solutions Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Obstetric Risk Assessment Solutions Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Obstetric Risk Assessment Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Obstetric Risk Assessment Solutions Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Obstetric Risk Assessment Solutions Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global Obstetric Risk Assessment Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Obstetric Risk Assessment Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Obstetric Risk Assessment Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Obstetric Risk Assessment Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Obstetric Risk Assessment Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Obstetric Risk Assessment Solutions market include Johns Hopkins University, Lightbeam Health Solutions, Dynamic Healthcare Systems, Evolent Health, GE Healthcare, Philips Healthcare, PerkinElmer, Fujifilm Healthcare and Canon Medical Systems, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Obstetric Risk Assessment Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Obstetric Risk Assessment Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Obstetric Risk Assessment Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Obstetric Risk Assessment Solutions market.

Obstetric Risk Assessment Solutions Segment by Company

Johns Hopkins University

Lightbeam Health Solutions

Dynamic Healthcare Systems

Evolent Health

GE Healthcare

Philips Healthcare

PerkinElmer

Fujifilm Healthcare

Canon Medical Systems

Nihon Kohden

Jumper Medical

Cerner Corporation

Health Catalyst

HBI Solutions

Obstetric Risk Assessment Solutions Segment by Type

Screening Assessment

Diagnostic Assessment

Dynamic Monitoring Assessment

Others

Obstetric Risk Assessment Solutions Segment by Application

Public Hospital

Private Hospital

Obstetric Risk Assessment Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Obstetric Risk Assessment Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Obstetric Risk Assessment Solutions key companies, revenue, market share, and recent developments.

3. To split the Obstetric Risk Assessment Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Obstetric Risk Assessment Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Obstetric Risk Assessment Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Obstetric Risk Assessment Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Obstetric Risk Assessment Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Obstetric Risk Assessment Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Obstetric Risk Assessment Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Obstetric Risk Assessment Solutions industry.

Chapter 3: Detailed analysis of Obstetric Risk Assessment Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Obstetric Risk Assessment Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Obstetric Risk Assessment Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Obstetric Risk Assessment Solutions Industry Trends Table 2. Obstetric Risk Assessment Solutions Industry Drivers Table 3. Obstetric Risk Assessment Solutions Industry Opportunities and Challenges Table 4. Obstetric Risk Assessment Solutions Industry Restraints Table 5. Global Obstetric Risk Assessment Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Obstetric Risk Assessment Solutions Revenue Share by Company (2021-2026) Table 7. Global Obstetric Risk Assessment Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Obstetric Risk Assessment Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Obstetric Risk Assessment Solutions Company, Product Type & Application Table 10. Global Obstetric Risk Assessment Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Obstetric Risk Assessment Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Screening Assessment Table 15. Significant Companies of Diagnostic Assessment Table 16. Significant Companies of Dynamic Monitoring Assessment Table 17. Significant Companies of Others Table 18. Global Obstetric Risk Assessment Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Obstetric Risk Assessment Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Obstetric Risk Assessment Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Obstetric Risk Assessment Solutions Sales Value Share by Type (2021-2026) Table 22. Global Obstetric Risk Assessment Solutions Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Public Hospital Table 24. Significant Companies of Private Hospital Table 25. Global Obstetric Risk Assessment Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Obstetric Risk Assessment Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Obstetric Risk Assessment Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Obstetric Risk Assessment Solutions Sales Value Share by Application (2021-2026) Table 29. Global Obstetric Risk Assessment Solutions Sales Value Share by Application (2027-2032) Table 30. Global Obstetric Risk Assessment Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Obstetric Risk Assessment Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Obstetric Risk Assessment Solutions Sales Value Share by Region (2021-2026) Table 33. Global Obstetric Risk Assessment Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Obstetric Risk Assessment Solutions Sales Value Share by Region (2027-2032) Table 35. Global Obstetric Risk Assessment Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Obstetric Risk Assessment Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Obstetric Risk Assessment Solutions Sales Value Market Share by Country (2021-2026) Table 38. Global Obstetric Risk Assessment Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Obstetric Risk Assessment Solutions Sales Value Market Share by Country (2027-2032) Table 40. Johns Hopkins University Company Information Table 41. Johns Hopkins University Business Overview Table 42. Johns Hopkins University Obstetric Risk Assessment Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Johns Hopkins University Obstetric Risk Assessment Solutions Product Portfolio Table 44. Johns Hopkins University Recent Development Table 45. Lightbeam Health Solutions Company Information Table 46. Lightbeam Health Solutions Business Overview Table 47. Lightbeam Health Solutions Obstetric Risk Assessment Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Lightbeam Health Solutions Obstetric Risk Assessment Solutions Product Portfolio Table 49. Lightbeam Health Solutions Recent Development Table 50. Dynamic Healthcare Systems Company Information Table 51. Dynamic Healthcare Systems Business Overview Table 52. Dynamic Healthcare Systems Obstetric Risk Assessment Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Dynamic Healthcare Systems Obstetric Risk Assessment Solutions Product Portfolio Table 54. Dynamic Healthcare Systems Recent Development Table 55. Evolent Health Company Information Table 56. Evolent Health Business Overview Table 57. Evolent Health Obstetric Risk Assessment Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Evolent Health Obstetric Risk Assessment Solutions Product Portfolio Table 59. Evolent Health Recent Development Table 60. GE Healthcare Company Information Table 61. GE Healthcare Business Overview Table 62. GE Healthcare Obstetric Risk Assessment Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. GE Healthcare Obstetric Risk Assessment Solutions Product Portfolio Table 64. GE Healthcare Recent Development Table 65. Philips Healthcare Company Information Table 66. Philips Healthcare Business Overview Table 67. Philips Healthcare Obstetric Risk Assessment Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Philips Healthcare Obstetric Risk Assessment Solutions Product Portfolio Table 69. Philips Healthcare Recent Development Table 70. PerkinElmer Company Information Table 71. PerkinElmer Business Overview Table 72. PerkinElmer Obstetric Risk Assessment Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. PerkinElmer Obstetric Risk Assessment Solutions Product Portfolio Table 74. PerkinElmer Recent Development Table 75. Fujifilm Healthcare Company Information Table 76. Fujifilm Healthcare Business Overview Table 77. Fujifilm Healthcare Obstetric Risk Assessment Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Fujifilm Healthcare Obstetric Risk Assessment Solutions Product Portfolio Table 79. Fujifilm Healthcare Recent Development Table 80. Canon Medical Systems Company Information Table 81. Canon Medical Systems Business Overview Table 82. Canon Medical Systems Obstetric Risk Assessment Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Canon Medical Systems Obstetric Risk Assessment Solutions Product Portfolio Table 84. Canon Medical Systems Recent Development Table 85. Nihon Kohden Company Information Table 86. Nihon Kohden Business Overview Table 87. Nihon Kohden Obstetric Risk Assessment Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Nihon Kohden Obstetric Risk Assessment Solutions Product Portfolio Table 89. Nihon Kohden Recent Development Table 90. Jumper Medical Company Information Table 91. Jumper Medical Business Overview Table 92. Jumper Medical Obstetric Risk Assessment Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Jumper Medical Obstetric Risk Assessment Solutions Product Portfolio Table 94. Jumper Medical Recent Development Table 95. Cerner Corporation Company Information Table 96. Cerner Corporation Business Overview Table 97. Cerner Corporation Obstetric Risk Assessment Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Cerner Corporation Obstetric Risk Assessment Solutions Product Portfolio Table 99. Cerner Corporation Recent Development Table 100. Health Catalyst Company Information Table 101. Health Catalyst Business Overview Table 102. Health Catalyst Obstetric Risk Assessment Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Health Catalyst Obstetric Risk Assessment Solutions Product Portfolio Table 104. Health Catalyst Recent Development Table 105. HBI Solutions Company Information Table 106. HBI Solutions Business Overview Table 107. HBI Solutions Obstetric Risk Assessment Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. HBI Solutions Obstetric Risk Assessment Solutions Product Portfolio Table 109. HBI Solutions Recent Development Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Obstetric Risk Assessment Solutions Product Image Figure 2. Global Obstetric Risk Assessment Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Obstetric Risk Assessment Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Obstetric Risk Assessment Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Screening Assessment Image Figure 8. Diagnostic Assessment Image Figure 9. Dynamic Monitoring Assessment Image Figure 10. Others Image Figure 11. Global Obstetric Risk Assessment Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Obstetric Risk Assessment Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Obstetric Risk Assessment Solutions Sales Value Share by Type (2021-2032) Figure 14. Public Hospital Image Figure 15. Private Hospital Image Figure 16. Global Obstetric Risk Assessment Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Obstetric Risk Assessment Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Obstetric Risk Assessment Solutions Sales Value Share by Application (2021-2032) Figure 19. Global Obstetric Risk Assessment Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Obstetric Risk Assessment Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Obstetric Risk Assessment Solutions Sales Value (2021-2032) & (US$ Million) Figure 22. North America Obstetric Risk Assessment Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Obstetric Risk Assessment Solutions Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Obstetric Risk Assessment Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Obstetric Risk Assessment Solutions Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Obstetric Risk Assessment Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Obstetric Risk Assessment Solutions Sales Value (2021-2032) & (US$ Million) Figure 28. South America Obstetric Risk Assessment Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Obstetric Risk Assessment Solutions Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Obstetric Risk Assessment Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Screening Assessment
  • Diagnostic Assessment
  • Dynamic Monitoring Assessment
  • Others
Applications
  • Public Hospital
  • Private Hospital
Companies covered
  • Johns Hopkins University
  • Lightbeam Health Solutions
  • Dynamic Healthcare Systems
  • Evolent Health
  • GE Healthcare
  • Philips Healthcare
  • PerkinElmer
  • Fujifilm Healthcare
  • Canon Medical Systems
  • Nihon Kohden
  • Jumper Medical
  • Cerner Corporation
  • Health Catalyst
  • HBI Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Obstetric Risk Assessment Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Obstetric Risk Assessment Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Obstetric Risk Assessment Solutions Market Dynamics
  1. 2.1 Obstetric Risk Assessment Solutions Industry Trends
  2. 2.2 Obstetric Risk Assessment Solutions Industry Drivers
  3. 2.3 Obstetric Risk Assessment Solutions Industry Opportunities and Challenges
  4. 2.4 Obstetric Risk Assessment Solutions Industry Restraints
3 Obstetric Risk Assessment Solutions Market by Company
  1. 3.1 Global Obstetric Risk Assessment Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Obstetric Risk Assessment Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Obstetric Risk Assessment Solutions Company Ranking (2024-2026)
  4. 3.4 Global Obstetric Risk Assessment Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Obstetric Risk Assessment Solutions Company Product Type and Application
  6. 3.6 Global Obstetric Risk Assessment Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Obstetric Risk Assessment Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Obstetric Risk Assessment Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Obstetric Risk Assessment Solutions Market by Type
  1. 4.1 Obstetric Risk Assessment Solutions Type Introduction
  2. 4.1.1 Screening Assessment
  3. 4.1.2 Diagnostic Assessment
  4. 4.1.3 Dynamic Monitoring Assessment
  5. 4.1.4 Others
  6. 4.2 Global Obstetric Risk Assessment Solutions Sales Value by Type
  7. 4.2.1 Global Obstetric Risk Assessment Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Obstetric Risk Assessment Solutions Sales Value by Type (2021-2032)
  9. 4.2.3 Global Obstetric Risk Assessment Solutions Sales Value Share by Type (2021-2032)
5 Obstetric Risk Assessment Solutions Market by Application
  1. 5.1 Obstetric Risk Assessment Solutions Application Introduction
  2. 5.1.1 Public Hospital
  3. 5.1.2 Private Hospital
  4. 5.2 Global Obstetric Risk Assessment Solutions Sales Value by Application
  5. 5.2.1 Global Obstetric Risk Assessment Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Obstetric Risk Assessment Solutions Sales Value by Application (2021-2032)
  7. 5.2.3 Global Obstetric Risk Assessment Solutions Sales Value Share by Application (2021-2032)
6 Obstetric Risk Assessment Solutions Regional Value Analysis
  1. 6.1 Global Obstetric Risk Assessment Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Obstetric Risk Assessment Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Obstetric Risk Assessment Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Obstetric Risk Assessment Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Obstetric Risk Assessment Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Obstetric Risk Assessment Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Obstetric Risk Assessment Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Obstetric Risk Assessment Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Obstetric Risk Assessment Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Obstetric Risk Assessment Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Obstetric Risk Assessment Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Obstetric Risk Assessment Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Obstetric Risk Assessment Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Obstetric Risk Assessment Solutions Sales Value Share by Country, 2025 VS 2032
7 Obstetric Risk Assessment Solutions Country-level Value Analysis
  1. 7.1 Global Obstetric Risk Assessment Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Obstetric Risk Assessment Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Obstetric Risk Assessment Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Obstetric Risk Assessment Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Obstetric Risk Assessment Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Obstetric Risk Assessment Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Obstetric Risk Assessment Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johns Hopkins University
  2. 8.1.1 Johns Hopkins University Company Information
  3. 8.1.2 Johns Hopkins University Business Overview
  4. 8.1.3 Johns Hopkins University Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johns Hopkins University Obstetric Risk Assessment Solutions Product Portfolio
  6. 8.1.5 Johns Hopkins University Recent Developments
  7. 8.2 Lightbeam Health Solutions
  8. 8.2.1 Lightbeam Health Solutions Company Information
  9. 8.2.2 Lightbeam Health Solutions Business Overview
  10. 8.2.3 Lightbeam Health Solutions Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lightbeam Health Solutions Obstetric Risk Assessment Solutions Product Portfolio
  12. 8.2.5 Lightbeam Health Solutions Recent Developments
  13. 8.3 Dynamic Healthcare Systems
  14. 8.3.1 Dynamic Healthcare Systems Company Information
  15. 8.3.2 Dynamic Healthcare Systems Business Overview
  16. 8.3.3 Dynamic Healthcare Systems Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dynamic Healthcare Systems Obstetric Risk Assessment Solutions Product Portfolio
  18. 8.3.5 Dynamic Healthcare Systems Recent Developments
  19. 8.4 Evolent Health
  20. 8.4.1 Evolent Health Company Information
  21. 8.4.2 Evolent Health Business Overview
  22. 8.4.3 Evolent Health Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Evolent Health Obstetric Risk Assessment Solutions Product Portfolio
  24. 8.4.5 Evolent Health Recent Developments
  25. 8.5 GE Healthcare
  26. 8.5.1 GE Healthcare Company Information
  27. 8.5.2 GE Healthcare Business Overview
  28. 8.5.3 GE Healthcare Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GE Healthcare Obstetric Risk Assessment Solutions Product Portfolio
  30. 8.5.5 GE Healthcare Recent Developments
  31. 8.6 Philips Healthcare
  32. 8.6.1 Philips Healthcare Company Information
  33. 8.6.2 Philips Healthcare Business Overview
  34. 8.6.3 Philips Healthcare Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Philips Healthcare Obstetric Risk Assessment Solutions Product Portfolio
  36. 8.6.5 Philips Healthcare Recent Developments
  37. 8.7 PerkinElmer
  38. 8.7.1 PerkinElmer Company Information
  39. 8.7.2 PerkinElmer Business Overview
  40. 8.7.3 PerkinElmer Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PerkinElmer Obstetric Risk Assessment Solutions Product Portfolio
  42. 8.7.5 PerkinElmer Recent Developments
  43. 8.8 Fujifilm Healthcare
  44. 8.8.1 Fujifilm Healthcare Company Information
  45. 8.8.2 Fujifilm Healthcare Business Overview
  46. 8.8.3 Fujifilm Healthcare Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fujifilm Healthcare Obstetric Risk Assessment Solutions Product Portfolio
  48. 8.8.5 Fujifilm Healthcare Recent Developments
  49. 8.9 Canon Medical Systems
  50. 8.9.1 Canon Medical Systems Company Information
  51. 8.9.2 Canon Medical Systems Business Overview
  52. 8.9.3 Canon Medical Systems Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Canon Medical Systems Obstetric Risk Assessment Solutions Product Portfolio
  54. 8.9.5 Canon Medical Systems Recent Developments
  55. 8.10 Nihon Kohden
  56. 8.10.1 Nihon Kohden Company Information
  57. 8.10.2 Nihon Kohden Business Overview
  58. 8.10.3 Nihon Kohden Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nihon Kohden Obstetric Risk Assessment Solutions Product Portfolio
  60. 8.10.5 Nihon Kohden Recent Developments
  61. 8.11 Jumper Medical
  62. 8.11.1 Jumper Medical Company Information
  63. 8.11.2 Jumper Medical Business Overview
  64. 8.11.3 Jumper Medical Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jumper Medical Obstetric Risk Assessment Solutions Product Portfolio
  66. 8.11.5 Jumper Medical Recent Developments
  67. 8.12 Cerner Corporation
  68. 8.12.1 Cerner Corporation Company Information
  69. 8.12.2 Cerner Corporation Business Overview
  70. 8.12.3 Cerner Corporation Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cerner Corporation Obstetric Risk Assessment Solutions Product Portfolio
  72. 8.12.5 Cerner Corporation Recent Developments
  73. 8.13 Health Catalyst
  74. 8.13.1 Health Catalyst Company Information
  75. 8.13.2 Health Catalyst Business Overview
  76. 8.13.3 Health Catalyst Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Health Catalyst Obstetric Risk Assessment Solutions Product Portfolio
  78. 8.13.5 Health Catalyst Recent Developments
  79. 8.14 HBI Solutions
  80. 8.14.1 HBI Solutions Company Information
  81. 8.14.2 HBI Solutions Business Overview
  82. 8.14.3 HBI Solutions Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
  83. 8.14.4 HBI Solutions Obstetric Risk Assessment Solutions Product Portfolio
  84. 8.14.5 HBI Solutions Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst